Application of artificial intelligence in predicting lymph node metastasis in breast cancer.

Autor: Windsor GO; Department of Diagnostic Imaging, Brown University, Providence, RI, United States., Bai H; Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, MD, United States., Lourenco AP; Department of Diagnostic Imaging, Brown University, Providence, RI, United States., Jiao Z; Department of Diagnostic Imaging, Brown University, Providence, RI, United States.

Publikováno v: Frontiers in radiology [Front Radiol] 2023 Feb 20; Vol. 3, pp. 928639. Date of Electronic Publication: 2023 Feb 20 (Print Publication: 2023).

In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.

Autor: Matossian MD; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Chang T; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Wright MK; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Sabol RA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Wathieu H; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Windsor GO; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Alzoubi MS; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., King CT; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Bursavich JB; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Ham AM; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Savoie JJ; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Nguyen K; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Baddoo M; Cancer Genetics Program, Tulane University School of Medicine, New Orleans, LA, USA., Flemington E; Cancer Genetics Program, Tulane University School of Medicine, New Orleans, LA, USA., Sirenko O; Molecular Devices LLC, San Jose, CA, USA., Cromwell EF; Protein Fluidics Inc, Burlingame, CA, USA., Hebert KL; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Lau F; Department of Surgery, Section of Plastic & Reconstructive Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Izadpanah R; Tulane Cancer Center, New Orleans, LA, USA., Brown H; Innogenomics Technologies LLC, New Orleans, LA, USA., Sinha S; Innogenomics Technologies LLC, New Orleans, LA, USA., Zabaleta J; Department of Pediatrics, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Riker AI; Cancer Service Line, Anne Arundel Medical Center, Luminis Health, DeCesaris Cancer Institute, Annapolis, MD, USA., Moroz K; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Miele L; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Zea AH; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Ochoa A; Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Bunnell BA; Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, TX, USA., Collins-Burow BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Cancer Center, New Orleans, LA, USA., Martin EC; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Burow ME; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Jan; Vol. 24 (1), pp. 127-144. Date of Electronic Publication: 2021 Aug 09.

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.

Autor: Matossian MD; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Van Hoang T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Wright MK; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Alzoubi MS; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Yan T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Chang T; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Wathieu H; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Windsor GO; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Hartono AB; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Lee S; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA., Zuercher WJ; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Drewry DH; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Wells C; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kapadia N; Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Buechlein A; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA., Fang F; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA., Nephew KP; Indiana University Center for Genomics and Bioinformatics, Bloomington, IN, USA.; Medical Sciences Program, Indiana University School of Medicine-Bloomington, Bloomington, IN, USA., Collins-Burow BM; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA., Burow ME; Department of Medicine, Tulane University School of Medicine, New Orleans, LA, USA. mburow@tulane.edu.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 189 (1), pp. 49-61. Date of Electronic Publication: 2021 Jul 01.